Granite Investment Partners, LLC Chroma Dex Corp. Transaction History

Granite Investment Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$2.54 - $4.75 $29,827 - $55,779	-11,743 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$2.83 - $4.61 $219,531 - $357,611	-77,573 Reduced 86.85%	11,743 $51,000
Q2 2019 Aug 07, 2019	SELL	$3.71 - $4.83 $290,763 - $378,541	-78,373 Reduced 46.74%	89,316 $415,000
Q1 2019 May 13, 2019	BUY	$3.2 - $4.19 $250,793 - $328,382	78,373 Added 87.75%	167,689 $702,000
Q1 2018 May 04, 2018	SELL	$4.05 - $6.46 $651,888 - $1.04 Million	-160,960 Reduced 64.31%	89,316 $375,000
Q3 2017 Nov 08, 2017	BUY	$2.91 - $4.71 $728,303 - $1.18 Million	250,276	250,276 $1.08 Million

16.4M

91.7K

18.9K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $249M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Granite Investment Partners, LLC with notifications on news.